Want to buy for someone else? You can purchase a token at check out.
Overview
- Recall at least two signs and symptoms of common eye disorders.
- Identify the risk factors for common eye disorders.
- Determine treatment interventions for common eye disorders.
Goals and Learning Outcomes
Vision loss can significantly impact a patient’s daily function and quality of life. Physical risks, such as falls and injury, and psychosocial consequences, such as depression and social isolation, are increased as a result of impaired vision. It is important as a healthcare provider that you are familiar with the guidelines for the prevention and detection of eye disorders in your patients.
Course Details
Course Originally Released on : 7/1/2024
Course Expiration Date : 12/31/2027
REL-ACU-0-PMEDS
Accreditations
NURSES
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Provider approved by the California Board of Registered Nursing, CEP#13791


Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, Kansas State Board of Nursing, Kentucky Board of Nursing, Michigan Board of Nursing, Mississippi Board of Nursing, New Hampshire Board of Nursing, New Mexico Board Of Nursing, North Dakota Board of Nursing, South Carolina Board Of Nursing and West Virginia Board Of Registered Nurses
Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.
Disclosures
None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
